Auria has a sensitivity of 92% which means out of 100 women with breast cancer, Auria would classify 92 of those women as clinically significant (or above the diagnostic threshold); the remaining 8 are identified as negative.

Auria has a specificity of 58%, which means out of 100 normal women, Auria would classify 58 of them as negative.

We have preferentially selected our algorithm to have a higher sensitivity in order to reduce the number of missed cancers (i.e. false negatives). As with all lab-developed tests, continued use of our assay will allow for optimization of the diagnostic parameters.

Yes, most FSA’s and HSA’s allow for purchase of at home laboratory tests, but please check with your benefits department to be sure. To receive your "super bill" or EOB for HSA/FSA reimbursement, please contact customer service. At this time, the cost of Auria is not covered by insurance.

Auria uses innovative proteomic science to give real-time results to aid in early detection. Auria measure levels of protein biomarkers in your tears that may be associated with an abnormality in the breast tissue or breast cancer.

Auria is designed to supplement routine screening and not replace it. Auria is for information and educational use only. It is not intended to be used for diagnostic purposes. If you feel a lump or have an area of concern, please see your health care provider.

Once your results are ready, you’ll be able to schedule a community educational consultation with our Breast Health Educators (BHE) through your dashboard. At your scheduled session you will meet with a BHE via a Zoom link that is emailed to you. During the educational consultation, the BHE will discuss Auria results, potential next steps, and other information related to breast health. You will have an opportunity to ask questions during the Q&A time.

Learn more about consultations HERE